HLB Life Care Signs Sales Agreement with Chong Kun Dang for CGM Device

HLB Life Care has signed a sales agreement with Chong Kun Dang for the continuous glucose monitoring (CGM) device “Picoring.”

From left, HLB Life Care CEO Kim Songsu, Ahn Cheolwoo, professor of endocrinology at Gangnam Severance Hospital and co-CEO of HLB Life Care, and Lee Gyuoong, head of marketing at Chong Kun Dang, pose for a commemorative photo on the 11th. HLB Life Care

According to HLB Life Care on November 13, Chong Kun Dang will handle distribution, sales, and marketing through hospitals and clinics in Korea, as well as the Chong Kun Dang Mall.

The Picoring continuous glucose monitoring device can be used by a wide age range, from pediatric diabetes patients aged 2 and older to adults with diabetes. A coin-sized or smaller sensor continuously measures changes in blood glucose levels for 15 days, 24 hours a day, without blood sampling. Its IP68-rated dustproof and waterproof performance makes it more convenient to use in everyday life.

The measured data can be shared and managed by healthcare professionals, patients, and caregivers through the dedicated smartphone app, “My Picoring.” At medical institutions, healthcare professionals can monitor more detailed patient glucose data through a dedicated web dashboard for patient monitoring and receive AI-based analysis reports.

An HLB Life Care representative said, “Through a close partnership and cooperation with Chong Kun Dang, we will work to expand access to continuous glucose monitoring devices and make a meaningful contribution to improving the quality of life of people with diabetes.”

This content was produced with the assistance of AI translation services.